Clearside Biomedical (CLSD) PT Lowered to $7 at JMP Securities
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/4/2026
- Wall St futures jump as Democrats sweep midterms
- CVS Health plans to split into two public companies by 2028
- UBS starts bullish coverage on Ferrari Group on luxury logistics growth
- Citi cuts Adobe rating on ’rising risk of a hard reset’
- Apple shares slip amid guidance for tightening margins, slowing services growth
Tweet
Share
E-mailGet Alerts CLSD Hot Sheet
Price: $0.41 --0%
Rating Summary:
4 Buy, 8 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 14 | Down: 17 | New: 12
Rating Summary:
4 Buy, 8 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 14 | Down: 17 | New: 12
Join SI Premium – FREE
JMP Securities analyst Jonathan Wolleben lowered the price target on Clearside Biomedical (NASDAQ: CLSD) to $7.00 (from $9.00) while maintaining a Market Outperform rating.
You May Also Be Interested In
- JPMorgan Downgrades LG Energy Solution (373220:KS) to Neutral
- LG Household & Health Care Ltd (0519000:KS) (LGHHF) PT Lowered to KRW200,000 at JPMorgan
- JPMorgan Upgrades Meitu Inc (1357:HK) (MEIUY) to Overweight
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
